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Antibody fragments (scFv) that bind specifically to particles of cucumber mosaic cucumovirus (CMV) were obtained from
a library which encodes a diverse array of synthetic antibody fragments, each displayed on the surface of filamentous
bacteriophage. After four rounds of selection and enrichment, several clones were obtained which produced scFv that
bound specifically to purified particles of CMV in ELISA. BstNI digestion of phagemid DNA resulted in the same restriction
pattern for all clones. The nucleotide sequences of three of the clones showed that they belonged to the human VH1 family
and that they had a complementarity determining region loop of 7 amino acids. Phage-displayed antibodies and soluble
scFv secreted by these clones reacted with particles of CMV in sap from infected plants in ELISA. In immunoblotting tests,
soluble scFv preparations reacted with SDS-denatured coat protein extracted from purified preparations of CMV isolates
belonging to either subgroup I or II and also with protein extracted by SDS treatment of seeds harvested from naturally
infected lupin plants. The results demonstrate the feasibility, and potential applicability, of recombinant antibody methods
in plant pathology. q 1995 Academic Press, Inc.
The use of polyclonal and monoclonal antibodies in such as poor immunogenicity, toxicity of the antigens, or
high production costs. However, it is not clear whetherplant virology has provided useful knowledge and insight
into the processes of infection in plants, and of transmis- such reagents would be of use for plant virus detection
and diagnosis. We have addressed this question by us-sion by vectors, as well as becoming the cornerstone of
the detection and diagnosis of virus diseases (1). Re- ing as antigen cucumber mosaic cucumovirus (CMV),
which is known to be a poor immunogen for the prepara-cently, it was shown that functional fragments of antibody
molecules can be expressed, fused to the viral coat pro- tion of antisera by conventional means (5). In this paper
we describe the production of scFv specific for CMV fromteins, on the surface of filamentous phage (phage dis-
play; 2, 3). These fragments comprise the heavy and light a synthetic phage display library and their application,
without further modification, to the detection of CMV inchain variable (antigen binding) domains of the antibody
molecules linked by 15 amino acids to form a single naturally infected plant tissues, in particular in seed from
polypeptide chain (scFv). Specific scFv can be obtained naturally infected lupin plants.
from a population of phages carrying many different scFv The scFv were obtained from the MRC human syn-
by binding to and then elution from antigen. The selected thetic scFv library (6). The library of 108 clones was
phage preparation can then be enriched for binders by constructed in vitro using polymerase chain reactions
reinfecting Escherichia coli with the eluted phage and (PCRs) to amplify the variable regions (VH and VL) of
repeating the procedure. In this way genetically pure human immunoglobulin genes. The VH and VL domains
populations of phage which encode the scFv can be contain three complementarity determining regions
obtained after several repeated cycles. Large combinato- (CDRs) of hypervariable sequence, and the variation in
rial phage display libraries have been produced con- these regions is largely responsible for the specificity of
taining108 different clones, and it has been shown that binding to antigen (6). PCRs were devised to produce
a range of recombinant immune reagents with diverse DNA encoding 50 germline VH gene segments (including
specificities can be isolated from such libraries (4). CDRs 1 and 2) combined with CDR 3s of between 4 and
Selection from phage display libraries yields specific 12 amino acids in length encoded by random nucleotide
antibody fragments without the need either to immunize sequences (7). The recombination of gene segments
animals or to use hybridoma technology and should, thereby mimicked the rearrangement of immunoglobulin
therefore, overcome several difficulties in the production VH genes that occurs in vivo. These rearranged VH genes
of conventional polyclonal sera or monoclonal antibodies were then combined with a single Vl3 chain in the
phagemid pHEN. The scFv are fused to the minor fd
phage coat protein pIII, an amber mutation between the1 To whom reprint requests should be addressed.
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(A405nm) greater than four times the background control
values (mean A405nm  0.38).
The DNA encoding scFv from each of these nine
clones gave the same pattern of DNA fragments after
digestion with BstNI (11), suggesting that all of the clones
were similar. DNA encoding the heavy chain of three
clones were further compared by sequencing single-
stranded DNA prepared from phage particles using
primer pHEN seq (5* CTA TGC GGC CCC ATT CA 3*)
and a DNA sequencing kit (USB). The sequences wereFIG. 1. Deduced amino acid sequence of the heavy chain of CMV-
analysed using the Sequence Analysis Workshop (SAW)specific scFv. Complementarity determining regions (CDR) are shown
in boldface. program (12). The sequences of the three clones were
identical and belonged to the human VH1 family, which
is well represented in humans (13). The sequences of
sequences encoding the scFv and pIII means that strains the CDR1 and CDR2 are the same as the germline gene
of E. coli that do not suppress the amber stop codon DP-14 (13). The library was designed to encode CDR3
(nonsuppressor strains) secrete soluble scFv (9). The lengths of 4 to 12 amino acids, and the CDR3 of each of
scFv have a 14-residue peptide (myc-tag) attached to the the clones sequenced was 7 amino acids long (Fig. 1).
C terminus which provides a means of detection and Phage-displayed antibody and soluble scFv were used
purification of soluble scFv using myc-tag-specific mono- to detect CMV in purified preparations or in extracts of
clonal antibody 9E10 (8). infected plants using different immunochemical tech-
The library stock was amplified and particles were niques. Soluble scFv were produced by inducing cultures
rescued by superinfection with helper phage M13VCS, of infected HB2151 (nonsupressor strain) bacteria over-
which supplies the viral genes to permit packaging of night at 257 with 1 mM IPTG (9). Periplasmic extracts
the phagemid DNA (10) and the display of the scFv–pIII containing scFv were made from cell pellets by osmotic
fusion proteins on phage (11). For each round of selec- shock, in addition the bacterial culture supernatants
tion, immunotubes (Nunc) were coated by incubation were filtered through a 0.45-mm filter.
with a purified preparation of CMV (isolate R from France) The phage-displayed antibody and the preparations of
at 50 mg/ml in 50 mM carbonate (coating) buffer, pH soluble scFv obtained either as periplasmic extracts or
9.6, overnight at 47. The tubes were then rinsed with as culture supernatants were tested in PTA–ELISA (14).
phosphate-buffered saline (PBS) and blocked with 2% Microtiter plates containing extracts of CMV strain Fny
nonfat dried milk (Marvel) in PBS. Phage preparations (subgroup I)-infected Nicotiana clevelandii and N. glu-
containing 1012 CFU were added to the tubes and incu- tinosa plants (sap dilution 0.1 g/ml in coating buffer) were
bated for 4 hr at room temperature (ca. 227). After exten- incubated 16 hr at 47 and then rinsed and blocked as
sive washing, by rinsing the tubes 20 times with PBS above. The scFv preparations were mixed 1:10 with
containing 0.05% Tween 20 and 20 times with PBS, bound monoclonal antibody 9E10 and incubated for 3 hr at room
phage was eluted with 100 mM trimethylamine and then temperature. A CMV strain LW (subgroupII) polyclonal
used to infect E. coli cells. Phage particles were rescued immunoglobulin preparation at 1 mg/ml was included in
by superinfection with helper phage. the test for comparison. The plates were rinsed and incu-
After the fourth round of selection, phage were rescued bated with anti-mouse (or anti-rabbit) alkaline phospha-
from single colonies of E. coli TG-1 by superinfection with tase conjugate (Sigma Immunochemicals) as appropriate
the helper phage M13VCS. The resulting phage particles
were collected by PEG precipitation from the culture flu-
TABLE 1ids and tested by ELISA. To assay binding to CMV, micro-
titer plates were coated with CMV (5 mg/ml in coating Absorbance Values (A405nm) Obtained in PTA–ELISA of Cucumber
buffer) and incubated with test solutions and then with Mosaic Virus (CMV), Tomato Aspermy Virus (TAV), and Tobacco Ne-
crosis Virus (TNV) Isolates Using scFv Recombinant Antibodypolyclonal anti-M13 alkaline phosphatase conjugate.
Bound alkaline phosphatase was assayed by its reaction
Virus isolatewith p-nitrophenyl phosphate (Sigma Immunochemicals).
scFva Noninfected
The polyclonal antiserum to M13VCS was produced by (PE dilution) CMV-Fny TAV TNV plant extract
immunization of a New Zealand white rabbit (8 1 1012
1:2 0.43b 0.06 0.09 0.09PFU/ml M13VCS in incomplete Freund’s adjuvant in-
1:5 0.21 0.13 0.1 0.08jected subcutaneously). Immunglobulin was precipitated
1:10 0.15 0.08 0.1 0.07
from the rabbit antiserum and conjugated to alkaline
phosphatase using glutaraldehyde. Twenty-four single a scFv preparation was a bacterial periplasmic extract (PE).
b Absorbance value (A405nm).colonies were tested and nine gave absorbance values
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The scFv was shown to react with CMV by immu-
noblotting and PTA–ELISA. In both tests the coat protein
was denatured to some extent. The scFv therefore proba-
bly bind to a continuous epitope. This is not unexpected
because the phage particles carrying the scFv were se-
lected by binding to immunotubes which had been
coated with CMV antigen diluted in carbonate buffer, pH
9.6, a procedure that probably disrupts CMV particles
destroying discontinuous epitopes.
Although the signal obtained in the immunoblots and
ELISA was weaker than that obtained with polyclonal
antiserum, the scFv were obtained after only four rounds
of selection from a human synthetic phage display library
and were used without any further modification. Monova-
lent scFv obtained from such phage libraries are known
to have good to moderate binding affinities and several
strategies have been suggested to improve functionalFIG. 2. Protein blots of purified preparations of CMV strains or ex-
tracts of lupin seeds (a) Probed with CMV-specific polyclonal antise- affinity such as formation of multimers (6). Thus, shorten-
rum. Lane 1, extract of infected lupin seed; lanes 2, 3, and 4, prepara- ing the linker between the VH and VL chains to enhance
tions of CMV strains Fny, LS, and LW, respectively; lane 5, noninfected the formation of bivalent molecules, which has been
seed; lane 6, TRV-PPK20. (b and c) Probed with CMV-specific scFv.
shown to improve the avidity of scFv, is a plausible ap-Lanes 7, 8, and 9, preparations of CMV strains Fny, LS, and LW, respec-
proach to improving the reactivity of our scFv (17, 18).tively; lane 10, TRV-PPK20; lane 11, CMV-LW; lanes 12 and 13, infected
seed extracts; lane 14, uninfected seed. For the blot in c, dormant lupin Other strategies for improving affinity would include
seed was soaked in water for 24 hr, then crushed and diluted 1:5 with chain shuffling (19) to combine the selected heavy chain
sample buffer, and centrifuged for 5 min at 5000 g before 15 ml of the with a repertoire of light chains. Also, new larger syn-
extract was loaded on the gels. The blot was probed with scFv and
thetic repertoires have been constructed recently (20),the 9E10 antibody for 4 hr before incubation with an anti-mouse alkaline
which should enhance the prospect of selecting scFvphosphatase conjugate. Coomassie staining showed a single band for
the purified CMV preparations. The additional bands detected by prob- with higher affinities.
ing with CMV-specific polyclonal antiserum are probably degradation The results reported here show that virus-specific scFv
products or dimers (in the case of the bands with the higher molecular were obtained quickly (after only four rounds of selec-
weight).
tion), and without recourse to animal immunizations, from
a synthetic phage display library. The results demon-
strate the feasibility of using recombinant antibody meth-followed by substrate. The scFv was specific for CMV-
Fny; it did not react with plant extracts containing tomato ods in plant virology and, with further modification to
improve avidity, we believe that such recombinant re-aspermy virus (TAV) or tobacco necrosis virus (TNV) (Ta-
ble 1). The polyclonal anti-CMV-LW immunoglobulin re- agents will play an important role in diagnosis and in
basic research on plant viruses in the future.acted weakly with TAV giving an A405nm value of 0.4 above
background in the ELISA where the homologous value
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